Page 1 - Title Page
SENTiBYFJA FDA PUBLIC AFFAIRS-# i6~ 2;2 AvD5 Pr9f4-S DRUGS CURRENTLY APPROVED 13Y THE FDA FOR AIDS AND AIDS-ASSOCIATED CONDITIONS February 1997 Drug Name Indicaion Firm Name [ Approval _ _ _ _ Date Retrovir Capsules Glaxo Wellcomne 19 M 87 (zidovudine, AZT) Retrovir Syrup Glaxo Wellcome 28 SEP 89 Retrovir Injection Glaxo Wellcome 02 FEB 90 Videx Bristol Myers. 09 OCT 91 (didanosirie, ddl) Squibb _____ Htid Hoffman-La 19 JUN 92 (zalcitabine, ddC)Roche zerit Bristol Myers. 24 JUN 94 (stavudine, d4T) ________ Squibb _P ivir Glaxo Wellcome 17 NOV 95 (lamzivuditte, 3TC) Invirase Hoffman-La 06 DEC 95 (saquinavir) Roche Nor*i Abbott 01 MAR 96 (ritconavir) Laboratories _____ Crixivan Merck &Co., Inc. 13 MAR 96 (mndinavir) __________ ViamneBoebringer 21 JUJN96 ________________ ________ Ingeiheim,,t Pharnaweuucals, Roferon-A for Kapoi's Schering-Plough 21 -NOV 88 (intecfron alpha-2b) Sw=cma Roche ____ Cytovene Infuion for CMV Retintis Syntex 23 JUN 89 (ganciolovir) ( 1111 5571095.0291.029